Month: September 2025

High Roller Launches New Online Casino Brand in Finland

Written by Customer Service on September 4, 2025. Posted in Public Companies.

New localized casino brand Kassuuu embraces Finnish-slang, culture, and player-first entertainment Las Vegas, Nevada, Sept. 04, 2025 (GLOBE NEWSWIRE) — High Roller Technologies (“High Roller” and the “Company”) (NYSE: ROLR), operator of the award-winning, premium online casino brands High Roller and Fruta, today announced the launch of Kassuuu, a new online casino brand developed specifically for the Finnish market. The brand’s name is drawn from Finnish slang: Kassu means casino, while KASSUUU! evokes the triumphant cheer of victory. This spirit is embodied in the Kassuuu Jackpot, a unique branded feature available on selected games, designed to amplify excitement while remaining clearly presented to players. “Kassu means casino, and KASSUUU is what you yell when a jackpot lands,” said Sara Nunes, Managing Director & Chief...

Fazoli’s Takes a Bite Out of National Cheese Pizza Day with Limited Time Offer

Written by Customer Service on September 4, 2025. Posted in Public Companies.

Celebrate with $9.99 Pizza and Breadsticks at America’s Favorite Italian Chain LOS ANGELES, Sept. 04, 2025 (GLOBE NEWSWIRE) — Fazoli’s, the legendary fast and fresh Italian chain known for its signature dishes and unlimited breadsticks owned by FAT Brands Inc., is slicing up an irresistible offer this year in honor of National Cheese Pizza Day. From Sept. 5 to Sept. 8, fans can enjoy a Whole Cheese Pizza and 8 of Fazoli’s fan-favorite Garlic Breadsticks for just $9.99, in-store and online with code PIZZA25. To make things even cheesier, Fazoli’s has also debuted their all-new pizza crust at participating locations – a flavorful introduction crafted to make every slice even more satisfying. “We wanted to make National Cheese Pizza Day a holiday worth celebrating by giving our fans even more unmatched flavor at a price that’s hard...

Cardiac Biotech Solutions, Inc. (CBSC) Signs Exclusive 5-Year Distribution Agreement with Noventis Medical Covering Costa Rica, Panama, Colombia, and Argentina

Written by Customer Service on September 4, 2025. Posted in Public Companies.

LAS VEGAS, Sept. 04, 2025 (GLOBE NEWSWIRE) — Cardiac Biotech Solutions, Inc. (OTCID: CBSC) (“CBSC” or the “Company”), a designer, manufacturer, and distributor of non-invasive ambulatory cardiac monitoring products, today announced the execution of a new distribution agreement with Noventis Medical, granting the Company five-year exclusive rights to distribute CBSC’s products across Costa Rica, Panama, Colombia, and Argentina. Under the terms of the agreement, Noventis Medical has committed to a total of $600,000 USD contract value for the distribution rights. In addition, the Company has granted Noventis a right of first refusal for any future distribution opportunities across other Central and South American countries, provided it can match the terms offered by other prospective partners. “We are delighted...

Vantage Drilling International Ltd. – Notice of Annual General Meeting

Written by Customer Service on September 4, 2025. Posted in Public Companies.

Dubai, Sept. 04, 2025 (GLOBE NEWSWIRE) — The annual general meeting of Vantage Drilling International Ltd. (the “Company“) will be held on 16 October 2025, at 11:00 a.m. Atlantic Time at the law offices of Conyers Dill & Pearman Limited, located at Richmond House, 2nd Floor, 12 Par-la-ville Road, Hamilton HM08, Bermuda. The notice of the annual general meeting is attached, together with the attendance and proxy forms. The notice is also available on the Company’s website https://vantagedrilling.com/. About the CompanyVantage Drilling International Ltd., a Bermuda exempted company, is an offshore drilling contractor. Vantage Drilling’s primary business is to contract drilling units, related equipment and work crews primarily on a dayrate basis to drill oil and natural gas wells globally for major, national...

Silexion Therapeutics Announces Selection of Contract Research Organization to Support Upcoming Phase 2/3 Clinical Trials for SIL204

Written by Customer Service on September 4, 2025. Posted in Public Companies.

Strategic CRO to Support Path to Phase 2/3 Trials Following Recently Demonstrated Groundbreaking 97% Inhibition Rates for SIL204 Phase 2/3 Clinical Trials Expected to Commence in First Half of 2026 Following Q4 2025 and Q1 2026 Regulatory Submissions CRO Brings Over 28 Years of Drug Development Experience and Proven Phase 3 Oncology Trial Expertise to Support Upcoming Trial GRAND CAYMAN, Cayman Islands, Sept. 04, 2025 (GLOBE NEWSWIRE) — Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion” or the “Company”), a clinical-stage biotechnology company pioneering RNA interference (RNAi) therapies for KRAS-driven cancers, today announced it has selected a contract research organization (“CRO”) to support its upcoming Phase 2/3 clinical trials for SIL204, the Company’s next-generation siRNA...

Epiq Acquires Inflection IT to Enhance Intapp Implementation Capabilities

Written by Customer Service on September 4, 2025. Posted in Mergers And Acquisitions.

Intapp platform consultancy joins Epiq to expand law firm advisory services NEW YORK, Sept. 04, 2025 (GLOBE NEWSWIRE) — Epiq announced today the acquisition of Inflection IT, the market-leading consultancy supporting the implementation of Intapp platform and applied AI solutions. Inflection IT consultants will join Fireman, an Epiq company, the premier consultancy exclusively focused on serving the legal space, to expand law firm advisory services within Epiq. Consultants at Inflection IT have a deep understanding of the wide range of Intapp products and technologies, with more than 1,000 Intapp projects completed for the world’s premier law firms. Epiq is a longtime Intapp Certified Implementation Partner, and this addition expands the company’s expertise and capabilities. “Joining the Epiq team brings together the best consultants...

Semnur Pharmaceuticals, Inc. (“Semnur”), a Majority-Owned Subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”), and Denali Capital Acquisition Corp. Announce Approval from Denali’s Shareholders of the Previously Announced Business Combination

Written by Customer Service on September 4, 2025. Posted in Mergers And Acquisitions.

PALO ALTO, Calif, Sept. 04, 2025 (GLOBE NEWSWIRE) — Semnur Pharmaceuticals, Inc. (“Semnur”), a majority-owned subsidiary of Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain and neurodegenerative and cardiometabolic disease, today announced that the shareholders of Denali Capital Acquisition Corp (“Denali”) approved the previously announced business combination with Semnur (the “Business Combination”). The Business Combination was approved by Denali’s shareholders at its Extraordinary General Meeting held on September 3, 2025 (the “Meeting”), along with all other proposals presented at the Meeting, each of which were set forth in...

CoinShares Expands Strategic U.S. Market Leadership with Launch of “The Advisor Series”

Written by Customer Service on September 4, 2025. Posted in Public Companies.

Peer-to-peer educational initiative reinforces commitment to capturing U.S. advisor market as part of global expansion strategy SAINT HELIER, Jersey – September 4, 2025 – CoinShares International Limited (Nasdaq Stockholm: CS; USOTCQX: CNSRF), Europe’s largest digital asset investment manager, today announced the launch of “The Advisor Series,” an exclusive educational video content platform that advances the company’s aggressive U.S. market expansion strategy through its strengthened partnership with TMX VettaFi. Strategic Market Positioning The initiative represents a significant milestone in CoinShares’ systematic approach to capturing market leadership in the world’s largest wealth management market. Following the strategic acquisition of Valkyrie in 2021, now CoinShares Valkyrie, CoinShares has...

H2O America Releases 2024 Corporate Sustainability Report

Written by Customer Service on September 4, 2025. Posted in Public Companies.

Progress on carbon goals, expanded community impact, and continued water quality excellenceH2O America 2024 Sustainability ReportCover of H2O America’s 2024 Sustainability Report.SAN JOSE, Calif., Sept. 04, 2025 (GLOBE NEWSWIRE) — H2O America (Nasdaq: HTO), one of the nation’s largest investor-owned water and wastewater utilities, today announced the release of its 2024 Corporate Sustainability Report. The report highlights the company’s sustainability and community impact achievements across its operations in California, Connecticut, Maine and Texas. “In 2024, we deepened our commitment to sustainability while continuing to deliver high-quality water and exceptional service,” said Andrew F. Walters, CEO of H2O America. “From expanding solar energy generation to launching our Force for Good Foundation, we’re proud...

Alvotech Meets Investors and Participates in a Fireside Chat at the Morgan Stanley 23rd Annual Global Healthcare Conference in New York

Written by Customer Service on September 4, 2025. Posted in Public Companies.

REYKJAVIK, Iceland, June 4, 2025 – Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its participation in the Morgan Stanley 23rd Annual Global Healthcare Conference, which will be held in New York, NY, September 8-10, 2025. Alvotech will be meeting with investors on Tuesday, September 9, 2025, and Dr. Balaji Prasad, Chief Strategy Officer, will participate in a fireside chat on Wednesday September 10, 2025, at 10:45 am EDT (14:45 GMT / 16:45 CET). A live webcast of the fireside chat will be available to the general public and can be accessed at https://investors.alvotech.com/events/event-details/morgan-stanley-23rd-annual-global-healthcare-conference-new-york. After the event, a recording will be available for replay for...

Month: September 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals